AIG Stock Analysis: American International | NYSE
Insurance - Diversified | NYSE, USA | Market Cap: 42.093m USD | 12M Return: -1.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 307M
EPS Trend: -12.6%
Qual. Beats: 0
Rev. Trend: -90.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
American International Group, Inc. (AIG) is a global insurance provider serving commercial, institutional, and individual customers across North America and international markets. The company operates through three reporting segments: North America Commercial, International Commercial, and Global Personal. AIGs product portfolio spans commercial property and casualty coverage (including general liability, workers compensation, marine, energy, aviation, political risk, and trade credit), personal lines such as auto, homeowners, and accident and health products, and niche offerings like extended warranty and high-net-worth insurance. Beyond underwriting, the company holds mortgage and loan receivables, including commercial mortgages and life insurance policy loans. Founded in 1919 and headquartered in New York, AIG is classified as a Multi-line Insurance company within the Financials sector and is one of the largest publicly traded U.S. insurers. As a large multiline carrier, AIG generates revenue primarily through insurance premiums and investment income earned on reserves retained between premium collection and claims payment, commonly referred to as underwriting float.
- AIG pursues separation of Life and Retirement business
- Catastrophe losses from major disasters pressure combined ratio
- Higher interest rates boost investment portfolio yield
| Net Income: 3.16b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.52 > 1.0 |
| NWC/Revenue: -67.10% < 20% (prev -65.86%; Δ -1.25% < -1%) |
| CFO/TA 0.02 > 3% & CFO 3.52b > Net Income 3.16b |
| Net Debt (-25.8b) to EBITDA (7.75b): -3.32 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (542.2m) vs 12m ago -9.52% < -2% |
| Gross Margin: 38.50% > 18% (prev 33.04%; Δ 5.46% > 0.5%) |
| Asset Turnover: 16.48% > 50% (prev 16.85%; Δ -0.37% > 0%) |
| Interest Coverage Ratio: 10.67 > 6 (EBIT TTM 4.31b / Interest Expense TTM 404.0m) |
| A: -0.11 (Total Current Assets 86.2b - Total Current Liabilities 104b) / Total Assets 162b |
| B: 0.23 (Retained Earnings 37.7b / Total Assets 162b) |
| C: 0.03 (EBIT TTM 4.31b / Avg Total Assets 162b) |
| D: 0.33 (Book Value of Equity 40.4b / Total Liabilities 121b) |
| Altman-Z'' = 0.56 = B |
| DSRI: 1.03 (Receivables 51.2b/51.1b, Revenue 26.6b/27.3b) |
| GMI: 0.86 (GM 33.04% / 38.50%) |
| AQI: 1.00 (AQ_t 0.46 / AQ_t-1 0.46) |
| SGI: 0.98 (Revenue 26.6b / 27.3b) |
| TATA: -0.00 (NI 3.16b - CFO 3.52b) / TA 162b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of July 13, 2026, the stock is trading at USD 79.17 with a total of 2,008,144 shares traded. Over the past week, the price has changed by -0.28%, over one month by +6.35%, over three months by +3.68% and over the past year by -1.70%.
Current recommended Stop Loss: 76.80 (which is 3% or 1.3 ATR below the current price).
American International has received a consensus analysts rating of 3.76. Therefore, it is recommended to hold AIG.
- StrongBuy: 5
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 88 | 11.1% |
P/E Trailing = 13.9771
P/E Forward = 9.8619
P/S = 1.5765
P/B = 1.0418
P/EG = 0.6488
Revenue TTM = 26.6b USD
EBIT TTM = 4.31b USD
EBITDA TTM = 7.75b USD
Long Term Debt = 9.16b USD (from longTermDebt, last quarter)
Short Term Debt = 165.0m USD (from shortTermDebt, last fiscal year)
Debt = 9.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -25.8b USD (calculated: Debt 9.16b - CCE 34.9b)
Enterprise Value = 16.3b USD (42.1b + Debt 9.16b - CCE 34.9b)
Interest Coverage Ratio = 10.67 (Ebit TTM 4.31b / Interest Expense TTM 404.0m)
EV/FCF = 4.64x (Enterprise Value 16.3b / FCF TTM 3.52b)
FCF Yield = 21.57% (FCF TTM 3.52b / Enterprise Value 16.3b)
FCF Margin = 13.23% (FCF TTM 3.52b / Revenue TTM 26.6b)
Net Margin = 11.86% (Net Income TTM 3.16b / Revenue TTM 26.6b)
Gross Margin = 38.50% ((Revenue TTM 26.6b - Cost of Revenue TTM 16.4b) / Revenue TTM)
Gross Margin QoQ = 47.74% (prev 33.92%)
Tobins Q-Ratio = 0.10 (Enterprise Value 16.3b / Total Assets 162b)
Interest Expense / Debt = 4.41% (Interest Expense 404.0m / Debt 9.16b)
Taxrate = 19.05% (744.0m / 3.91b)
NOPAT = 3.49b (EBIT 4.31b * (1 - 19.05%))
Current Ratio = 0.83 (Total Current Assets 86.2b / Total Current Liabilities 104b)
Debt / Equity = 0.23 (Debt 9.16b / totalStockholderEquity, last quarter 40.4b)
Debt / EBITDA = -3.32 (Net Debt -25.8b / EBITDA 7.75b)
Debt / FCF = -7.31 (Net Debt -25.8b / FCF TTM 3.52b)
Total Stockholder Equity = 41.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.95% (Net Income 3.16b / Total Assets 162b)
RoE = 7.70% (Net Income TTM 3.16b / Total Stockholder Equity 41.0b)
RoCE = 8.59% (EBIT 4.31b / Capital Employed (Equity 41.0b + L.T.Debt 9.16b))
RoIC = 6.20% (NOPAT 3.49b / Invested Capital 56.3b)
WACC = 6.72% (E(42.1b)/V(51.2b) * Re(7.40%) + D(9.16b)/V(51.2b) * Rd(4.41%) * (1-Tc(0.19)))
Discount Rate = 7.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -11.18%
[DCF] Terminal Value 77.97% ; FCFF base≈3.19b ; Y1≈3.66b ; Y5≈5.39b
[DCF] Fair Price = 201.5 (EV 81.1b - Net Debt -25.8b = Equity 107b / Shares 530.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -12.57 | EPS CAGR: -3.37% | SUE: 0.71 | # QB: 0
Revenue Correlation: -90.02 | Revenue CAGR: -14.89% | SUE: -0.21 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.94 | Chg30d=+0.08% | Revisions=-40% | Analysts=18
EPS next Quarter (2026-09-30): EPS=1.83 | Chg30d=-0.10% | Revisions=+47% | Analysts=18
EPS current Year (2026-12-31): EPS=8.03 | Chg30d=-0.00% | Revisions=+87% | GrowthEPS=+13.3% | GrowthRev=+9.0%
EPS next Year (2027-12-31): EPS=8.90 | Chg30d=+0.06% | Revisions=+17% | GrowthEPS=+10.8% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: +64% (up=33, down=6)